Seth Lederman

Insider Reports History

Entity
Individual
Location
C/O Tonix Pharmaceuticals Holding Corp, 509 Madison Ave., Suite 306, New York, NY
Signature
/s/ Seth Lederman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Seth Lederman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tonix Pharmaceuticals Holding Corp. Chief Executive Officer, Director Stock Option 1.31M Feb 27, 2024 Direct

Insider Reports Filed by Seth Lederman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TNXP Tonix Pharmaceuticals Holding Corp. Feb 27, 2024 3 $0 4/A Mar 6, 2024 Chief Executive Officer, Director
TNXP Tonix Pharmaceuticals Holding Corp. Feb 27, 2024 3 $0 4 Feb 29, 2024 Chief Executive Officer, Director
TNXP Tonix Pharmaceuticals Holding Corp. Feb 23, 2023 2 $0 4 Feb 24, 2023 Chief Executive Officer, Director
TNXP Tonix Pharmaceuticals Holding Corp. Jun 29, 2022 1 $34.2K 4 Jul 1, 2022 Chief Executive Officer, Director
TNXP Tonix Pharmaceuticals Holding Corp. Mar 25, 2022 1 $24.5K 4 Mar 28, 2022 Chief Executive Officer, Director
TNXP Tonix Pharmaceuticals Holding Corp. Feb 15, 2022 4 $0 4 Feb 17, 2022 Chief Executive Officer, Director
TNXP Tonix Pharmaceuticals Holding Corp. Sep 28, 2021 1 $7.32K 4 Sep 28, 2021 Chief Executive Officer, Director